2017 Executive Sponsor
2017 Associate Sponsors
2017 Technology Sponsors
2017 Media Partners
2016 Sponsors / Exhibitors
3M Drug Delivery Systems is a global leader and innovator for inhalation and transdermal drug delivery.
Between drug discovery and commercialization, we offer:
- Innovative and proven technology
- Global regulatory expertise
- Commercial manufacturing
- Broad range of customizable system components
- Product development services
Our expertise increases your opportunity for success. Visit www.3m.com/dds.
Balda Healthcare is one of the leading global providers of complete packaging solutions for the Pharmaceutical industry. Also an OEM manufacturer of customized healthcare products and innovative packaging made of plastic and glass, including development, industrialization, injection molding (cleanroom), surface decoration, assembly of complete systems, and assisting with regulatory approvals. Visit www.balda-group.com.
Battelle combines medical device design and development, formulation expertise and human centric design to create innovative drug delivery systems that condense the development timeline and get our clients’ drugs to market faster. Battelle’s cross-disciplinary teams of experts mitigate risk and cut a clear path to regulatory approval for pharmaceutical companies looking to gain a competitive edge. Visit us at www.battelle.org.
Through cutting-edge science and medicine, Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For more information visit www.biogen.com.
Enable Injections is a late-stage startup company that has developed a disposable body-worn bolus injector to deliver high viscosity/volume payloads up to 20cc. The system uses a standard vial, cartridge or syringe container closure, and can automatically mix lyophilized solutions. Founded March 2010, the company has R&D, operations and manufacturing facilities in Cincinnati, Ohio. Visit us at enableinjections.com.
iO life science, formerly LUNAR Lifesciences, partners with healthcare providers to deliver strategy, design and engineering services for medical system and device development with compliance at the core. By unveiling user needs and key value propositions at the onset, we help clients to innovate in a meaningful way.
Creative expression and design-engineering cross fertilization are central to our product development success. By engaging seasoned worldwide resources, iO life bridges award winning, user centric design with cutting edge technology for first rate product development at considerable value.
This global approach coupled with our proven risk-managed process allows iO life to scale effectively and reduce time to market. Ultimately, we provide patients and providers with solutions that adapt to individual lifestyles and deliver measurable outcomes. Start a project at: iolifescience.com
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, please visit us at www.pfizer.com.
PharmaCircle is a leading provider of global information and analytics on drugs, biologics and combination products in all stages of development. PharmaCircle’s premier database delivers an in depth view into drug development and innovation, examining more than 135,000 pipeline programs and marketed products, and the business portfolios and transactions of nearly 15,000 companies worldwide. PharmaCircle also provides expert analyses on more than 5,700 drug delivery technologies and devices. For more information visit: www.pharmacircle.com
Phillips-Medisize, is a technology-based provider of outsourced design and manufacturing services, with a significant business in the drug delivery space, as well as, single-use surgical medical devices, and therapeutic products. The company has expertise in high-speed manufacturing and automated inspection technologies. With early engagement in the design process, customers can expect accelerated speed to market for the products they chose to outsource. For more information, visit www.phillipsmedisize.com.
3P helps Medical Devices and Pharmaceutical companies to de-risk new product development and reduce time-to-market by over 60%. We offer a powerful combination of product development and custom automation skills and methodologies that help customers develop and commercialise new products at lower cost and lower risk. We design and manufacture scalable production solutions, from lab-scale and bench-top equipment to pilot plant and full-scale production systems. Our specialisms include design and manufacture of cleanroom and aseptic processes, powder and liquid filling, parenteral device filling and finishing and device assembly and test. Our product experience includes reconstitution syringes, inhalers, pre-filled syringes, sustained release depot drugs, capsules, cartridges and vials. Visit us on stand where we will be demonstrating our patented DCI reconstitution syringe and E-Mix reconstitution mixing technologies. As reflected in our name, we deliver Product, Process and Production solutions. Visit www.3pinnovation.com.
Adare is a global specialty pharmaceutical company focused on developing innovative products that can improve the lives of patients whose treatment needs are not fully addressed by current medications. Over 40 products incorporating Adare taste-masking, customized drug release, and bioavailability enhancement proprietary technologies have been commercialized around the world. Visit www.adarepharma.com
Albumedix develops albumin-based products and technologies for advanced drug and vaccine formulation, extended drug half-life and improved drug delivery. Learn more at http://albumedix.com
Altus Formulation is a drug formulation and development company leveraging its patent protected technologies to develop novel value added, cost effective new products for ourselves and our clients. Altus technologies include the INTELLITAB abuse deterrent platform, FLEXITAB breakable and alcohol resistant sustained release tablets and SmartCelle parenteral formulations enabling long lasting injections of highly insoluble drugs. For more information, visit Altus at www.altusformulation.com and our sister company PPI at www.polymericparticles.com.
Bespak, a Consort Medical business, is a global market leader in the development and manufacture of drug delivery devices for Inhalation and Injectables markets. Bespak has contributed to the design, development and industrialisation of some of the world’s leading medical devices, manufacturing more than 550m devices each year. Learn more at www.bespak.com
For 20 years, BIOCORP has been developing and producing medical devices for the pharmaceutical industry, enhancing drug reconstitution, packaging and delivery. Recognized for its expertise in device R&D, BIOCORP has incorporated software development capacities to offer connected drug delivery systems in order to meet the evolving needs of patients and improve treatment adherence. Learn more at www.biocorp.fr.
Cambridge Design Partnership is an independent innovation and product development consultancy with offices in Cambridge, UK and Palo Alto, USA. Over the last 20 years, some of the world’s largest companies have trusted us with their most important product development programmes. We provide an integrated and holistic product development capability through our highly qualified team, well equipped development labs and ISO 13485/9001 approved methods. This encompasses research and strategy; design, technology and digital innovation; product development and manufacturing support including short run manufacture. Learn more about us at www.cambridge-design.co.uk
Credence MedSystems is a medical technology company focused on delivering medications safely for the benefit of patients, caregivers and partners. The Companion Safety Syringe System was born from Credence’s philosophy of Innovation Without Change. The Companion offers our pharmaceutical partners a simplified path to commercialization of a best-in-class delivery system by providing passive safety and reuse prevention while using existing primary package components. The Companion is available in luer needle, staked needle and dual chamber reconstitution configurations. In all cases, the user performs the injection, receives end-of-dose cues and then the needle automatically retracts into the syringe, which is disabled. Visit us at www.credencemed.com.
Cristal Therapeutics is a clinical stage pharmaceutical company developing the next generation nanomedicines based on its proprietary CriPec® platform to treat various diseases, including cancer. CriPec is perfectly suited for the development of highly customizable (targeted) nanomedicines with superior efficacy and safety profiles. The most advanced product in development is CriPec docetaxel for the treatment of solid tumours. Learn more at http://cristaltherapeutics.com.
CritiTech’s Bioavailability Optimization Technology™ represents the next generation in micronization, providing unique, excipient free nanoparticles with an exponential increase in surface area. BOT™ improves dissolution leading to improved pharmacokinetics in poorly soluble new chemical entities or reformulating an existing drug for an improved 2nd generation product utilizing a 505(b)(2) pathway. Learn more about us at http://crititech.com.
Datwyler Sealing Solutions develops, designs, and manufactures components for injectable packaging and drug delivery systems. Their products and services are built on high-quality materials and innovative technologies that support the pharmaceutical industry’s efforts towards safe and effective drug delivery for a healthier world. Visit us at www.datwyler.com
DelSiTech is a drug delivery and drug development company that works with its partners to turn their active agents into novel drug products. The company’s technology, Silica Matrix, is a biodegradable, biocompatible controlled/extended release platform for non-oral dosage forms. Silica Matrix is suitable for delivery of small molecules and biologics as well as offering thermostability and abuse deterrent properties. DelSiTech also develops its own supergeneric drug products to address significant unmet medical and commercial needs. 1308 is a 3 month hepatitis B product that will enter Phase I this year. Learn more at www.delsitech.com.
DisperSol has developed KinetiSol® for commercially manufacturing amorphous solid dispersions. KinetiSol® can achieve greater solubility enhancement and drug loading than spray drying or melt extrusion. It works with drugs & excipients unprocessable by those technologies. A lab-scale version of the technology will be offered to select partners in 2017. Learn more at www.dispersoltech.com.
Emisphere Technologies, Inc. is a pharmaceutical and drug delivery company. The Company launched its first prescription product, oral Eligen B12™, in the U.S. in March 2015 and we are currently engaged in strategic discussions to optimize its economic value in the U.S. and global markets. Beyond Eligen B12™, the Company utilizes its proprietary Eligen® Technology to create new oral formulations of therapeutic agents. Emisphere is currently partnered with global pharmaceutical companies for the development of new orally delivered therapeutics. For more information, please visit www.emisphere.com.
Entera Bio is a clinical-stage biopharmaceutical company focused on the development of novel oral drugs comprising large molecule APIs. Entera is currently applying its technology to teriparatide for the treatment of hypoparathyroidism, osteoporosis, and bone healing. Entera is managed by a knowledgeable team with years of experience in drug development. Learn more at www.enterabio.com.
Evonik Industries, a global leader in specialty chemicals, provides drug delivery technologies, API manufacturing, intermediates, ingredients for nutraceuticals, amino acids and derivatives. Drug delivery technologies include formulation development services, solubility enhancement, functional excipients, bioresorbable polymers and GMP manufacturing for oral and parenteral formulations. Advanced delivery technologies for extended-release parenterals are offered for small molecules, peptides, proteins, antibodies, and nucleic acids. Learn more at www.evonik.com/healthcare.
Halozyme focuses on developing and commercializing novel enzymatic therapies that target the tumor microenvironment or facilitate drug delivery. Our proprietary product, the ENHANZE™ drug delivery platform, supports strong, value-driving partnerships with leading pharmaceutical companies including Roche, Baxalta, Pfizer, Janssen, AbbVie and Lilly. The ENHANZE™ platform has sales in 50+ countries through three product approvals. For more information, visit www.halozyme.com.
InnoCore Pharmaceuticals is a biopharmaceutical drug delivery company specialized in the development of complex parenteral sustained release formulations. By using our proprietary biodegradable polymers e.g. microspheres and solid implants, we develop long acting and minimally invasive drug delivery products of small, medium sized (peptides) and large (proteins, antibodies) drug molecules. Learn more at www.innocorepharma.
InSitu Biologics develops and manufactures implantable timed release products composed of our proprietary tunable, bio-polymeric hydrogel, Matrix™. The physical properties allow us to create less viscous products for small spaces and more viscous products that prevent migration. We are currently pursuing applications for delivery in soft and bone tissue(s). Learn more at www.insitubiologics.com
Insulet Corporation is an innovative medical device company based in Billerica, Massachusetts. Insulet Corporation designs and manufactures the OmniPod Drug Delivery and Diabetes Management Systems. The OmniPod is an easy-to-use, programmable, body-worn, subcutaneous infusion pump used to treat diabetes and infertility. Learn more at www.insulet.com.
Intezyne Technologies, Inc was founded on the premise that post-administration stability of nanoparticles is key to clinical success. An iron-stabilized polymer nanoparticle platform, IVECT, delivers more drug to the tumor, resulting in a safer and more effective treatment. The lead IVECT therapeutic, IT-141, has IND approval. Learn more at www.intezyne.com.
IntraTab™ with our Sublingual Drug Delivery Technology™ (SDDT™) sets a new standard in rapid oral delivery of pharmaceuticals. SDDT™ is the first and only patented delivery technology that transports APIs which are not natively amenable to transmucosal delivery. Learn more at www.intratablabs.com
Leon’s business is to create new formulations of drugs by innovating the underlying pharmaceutical technology of a finished product. Its proprietary and patented MJR nano-technology can be used to improve the pharmacology of a drug, change the route of administration, and improve the overall clinical/safety/cost profile of a drug. Learn more about us at leon-nanodrugs.com.
Liquidia Technologies is a biopharmaceutical company that has pioneered simple, elegant solutions to improve the performance of medicines by precisely engineering drug particles in a virtually unlimited number of compositions, sizes, and shapes. PRINT® enabled product candidates have entered clinical development in pulmonary diseases (inhalation), post-operative pain management (injection) and ophthalmology (implants). In addition to building its own pipeline, Liquidia actively partners with collaborators, including GlaxoSmithKline, to expand the applications for PRINT® technology across the life-science industry. More information is available at www.liquidia.com.
Lucideon is an independent materials technology company that partners with pharmaceutical companies around the world to commercialise innovative drug delivery technologies, in particular inorganic controlled release for oral formulations.
Benefits of Lucideon’s platform technology include better control of carrier properties, versatility in delivery routes and a green manufacturing process. For more information, visit www.lucideon.com.
Medherant develops transdermal patches using its novel Tepi-Patch® technology. Its unique solvent-free adhesive allows direct dissolution of a wide range of drugs achieving high drug loading, sustained strong drug release and excellent patch adhesion. TepiPatch® can improve upon existing patches or allow development of patches for hard to formulate drugs. For more information, please visit www.medherant.co.uk.
MedinCell develops game-changing technologies to improve worldwide access to medicine and enable better treatment quality. Combining rapid formulation and low manufacturing costs with efficiency and compliance-related attributes, the BEPO drug delivery system can provide a controlled release of selected API for days, weeks or months after a simple subcutaneous injection. Learn more at www.medincell.com.
Microchips Biotech, Inc is dedicated to improving the lives of patients by revolutionizing drug delivery. Our microchip-based implant has the potential to address significant unmet needs by simplifying dosing regimens and enhancing compliance for patients who need frequent dosing or require regular injections. We are developing applications for the microchip-based implant in multiple therapeutic indications and partner with industry and foundations to meet patient needs across the globe. For more information, visit www.microchipsbiotech.com.
Micron Biomedical is a clinical-stage biopharmaceutical company, with funding from the Gates Foundation, CDC, pharmaceutical partners, and others, on a rapid path to bring to market drugs and vaccines that are formulated into a proprietary microneedle patch technology that simplifies and improves the way actives are delivered, stored, and distributed. Learn more about us at http://micronbiomedical.com.
Nanologica is a Swedish nanotechnology company with world-leading expertise in porous silica materials. The patented technology platform enables the use of nano-structured silica for applications in therapeutics and drug delivery. The company addresses major challenges in drug development by providing tailor-made solutions for controlled release and enhanced bioavailability. With cutting-edge research, silica particles can be fine-tuned to fit the API. Nanologica has, over the last ten years, successfully combined unique know-how in the field of materials technology with a genuine interest in solving real problems in drug development, including NCEs and generic formulations. In parallel, the company drives internal assets that address unmet medical needs by utilizing the unique properties of Nanologica’s technology. Silica-based drug delivery systems can contribute to increased success rate of commercializing new therapeutics and reformulations. Visit http://www.nanologica.com
Nemera is a world leader in the design, development and manufacturing of drug delivery solutions for the pharmaceutical, biotechnology & generics industries.
Its expertise covers all five modes of delivery: parenteral (auto-injectors, pens, passive safety devices & implanters), ophthalmic (multidose preservative-free eyedroppers), nasal, buccal, auricular(pumps, valves and actuators for sprays), dermal and transdermal (airless & atmospheric dispensers), pulmonary (pMDIs, DPIs).
Nemera leverages decades of manufacturing and development experience in the device segment from full development of standard innovative products, such as the passive safety device for pre-filled syringes Safe’n’Sound® and the 2-step auto-injector Safelia®, to pure contract manufacturing, through customized solutions. Learn more at www.nemera.net.
Oakwood is focused on the design, development, and aseptic manufacturing of sustained-release injectable microsphere products. We partner with companies in need of formulation development of their own products into sustained-release injectable form or contract manufacturing of their injectable drug. Oakwood has expertise in development of sustained-release injectable products using our patented microsphere technology. With our state of the art FDA approved cGMP aseptic manufacturing facility, Oakwood provides long term full-service supply and testing of aseptic injectable products to partners– from clinical trial material to commercial product. Learn more at www.oakwoodlabs.com
Portal Instruments is developing and commercializing a highly innovative needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for chronic diseases. Portal’s needle-free delivery technology is derived from research at MIT and enables the administration of high viscosity biologic drugs with significantly less discomfort and without the anxiety of handling needles. Using precise pressure technology, the injection is administered through the skin via a jet the size of a strand of hair, ensuring optimal comfort. Real time tracking and reporting sets a new standard for interactivity between the patient and care teams, monitoring adherence and potentially improving patient outcomes. For more information, visit www.portalinstruments.com.
ProMed specializes in the molding of silicone and thermoplastic components and leverages this expertise to manufacture drug releasing implants and combination devices. From preclinical materials to packaged products, ProMed supports pharmaceutical companies in the contract manufacturing of extended release formulations including subcutaneous implants, IUS, intravaginal rings, and ophthalmic implants. Visit us at www.promedpharmallc.com.
Quantex is the innovative leader in single-use disposable pump technology. We have a catalogue of single-use pumps and also provide a design and development service for custom applications. Our engineers and designers are on hand to provide design expertise throughout the development programme and assistance into volume production. Quantex & Vernay have formed a strategic partnership to bring single-use precision pumps to the flow control market. In addition to performing a business development role Vernay can support the volume manufacture of Quantex pumps. Visit our websites to learn more about Quantex and Vernay.
QuiO is a digital healthcare company that provides smart injection devices and connected software for monitoring adherence to injectable therapies in real-time. The company’s SmartinjectorTM device platform includes reusable, disposable and wearable injectors. Each device is fully-connected for wireless communication with the company’s cloud-based software, no smartphone or syncing required. Learn more at www.quio.com
For more than 25 years, Quotient Clinical has brought innovation to drug product development programs for pharmaceutical and biotechnology customers worldwide. Quotient’s unique Translational Pharmaceutics® approach integrates formulation development, real-time GMP manufacturing and clinical testing within a single location, significantly reducing the time and cost of bringing a drug to market. Learn more about us at www.quotientclinical.com.
Renishaw is applying precision engineering technology to the challenges of medical research, diagnostics and surgical procedures. Our aim is to help leading clinicians to enhance the safety and cost-effectiveness of their procedures, improving patient outcomes through accurate delivery and development of implantable devices.
Our healthcare product portfolio includes medical devices, planning software and surgical robotic systems for use in procedures such as deep brain stimulation (DBS) for Parkinson’s disease, and Stereoelectroencephalography (SEEG) for the treatment of epilepsy. We also manufacture patient specific implants (PSI) for craniomaxillofacial (CMF) surgery, often required as a result of trauma or oncology therapy. Visit us at www.renishaw.com/en.
Serina Therapeutics, Inc has developed a proprietary drug delivery polymer technology based upon the water soluble polymer poly(2-oxazoline), or POZ™. We are developing a pipeline of proprietary and partnered programs applying this platform to cancer, pain, and neurological diseases. Our most advanced program is SER-214, which is in Phase I development in patients with Parkinson’s disease. SER-214 is a once-weekly subcutaneous injection that delivers a potent dopamine agonist continuously, providing continuous dopaminergic stimulation.
Starpharma is a world leader in the development of dendrimer products for pharmaceutical, life-science and other applications. Starpharma has unique breadth in its programs (both internal and partnered), which all benefit from its proprietary dendrimer technology. In human health, Starpharma has two core development programs: DEP™ dendrimer drug delivery platform (passive and targeted) and the VivaGel® antimicrobial/antiviral portfolio. The DEP™ platform provides multiple opportunities to accelerate product development, enhance therapeutic utility and lower development risk of existing products and NCE’s, developing “first-in-class” therapies. For more information, visit www.starpharma.com.
Sensile Medical is a leading company in the area of micro-pumps and patch-pumps. These pumps are increasingly being used to enable Large-Volume Sub-Cutaneous delivery of modern biotech and pharmaceutical products for self-administration by patients. Sensile Medical solutions utilize electronically controlled rotary piston pump technology for highly accurate dosing regimens, enabling a broad range of drug delivery options. Founded in 2004, Sensile Medical is located in Haegendorf, Switzerland. Learn more at http://sensile-medical.com.
SpineThera designs and develops sustained-release, injectable drugs to meet the unique safety requirements for administration in and near the spine. Our goal is to develop proprietary drugs that offer patients and physicians new treatment options that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs. Learn more at www.spinethera.com.
West works side-by-side with its healthcare partners from concept to the patient, designing and manufacturing packaging, diagnostic and delivery systems that promote efficiency, reliability and safety. West leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge pharmaceutical product testing, development and packaging. Learn more at www.westpharma.com
BAUMANN – a global leading spring and stamping manufacturer with dedicated medical approach (ISO13485). We are your competent and reliable development partner in drug delivery device projects. Visit us at www.baumann-group.com.
Your Idea – Our Drive. Buehler Motor partners with pharmaceutical, biotech and medical device companies to develop and produce custom motion systems which enable specialized drug delivery. One Stop Drive Solutions. Complete Buehler Motor drive solutions combine DC/BLDC/stepper motors & gear motors, sensors, software, electronics, and actuators within a single assembly. For more information visit www.buehlermotor.com.
CMC Consulting Group is an international firm providing integrated transaction advisory, management consulting, medical affairs advisory and innovative research to companies in the healthcare and life science industries. CMC’s clients receive the knowledge, expertise and value-added guidance of both a strategy and medical affairs consulting firm and an investment bank combined into one industry specialist. Learn more at www.cmc-co.net.
CSS is a leading international manufacturer of precision springs and metal components. We are focused on serving the medical industry and offer early engineering involvement. CSS is experienced working with drug delivery devices and all types of medical instruments, sensors and devices, providing top-flight components so that your products can function flawlessly. Learn more at www.ctspring.com
At Haselmeier we work in close cooperation with our pharmaceutical partners to create and deliver the safest and easiest to use injection devices for their patients. Our proven device platforms, world leading engineering and global manufacturing capabilities combined with an intense focus on patient needs provides our partners with a total product solution that helps improve patients’ lives. Visit us at http://haselmeier.com
Infuseon Therapeutics, Inc enables therapeutic delivery to the brain via the patented Cleveland Multiport Catheter system, which can accurately delivery therapeutics that would otherwise be prevented from reaching their target by the Blood Brain Barrier. Visit www.infuseontherapeutics.com.
Founded in 1995, MANTA develops innovative products in the medical, consumer, business, sporting goods, and industrial markets. Our team’s multi-disciplinary expertise provides the basis for broad thinking that leads to groundbreaking concepts and production-ready solutions. Learn more at www.mantadesign.com
Maxon motor is a long-time partner of leading medical technology companies worldwide and provides system solutions by combining DC motors, gears and controllers into high precision intelligent drives. With over 50 years of experience, high-tech innovations and superior product quality, maxon is the reliable partner in drive technology. Individual, customized drive solutions is our greatest strength. For more information, visit www.maxonmotorusa.com.
Polysciences, Inc provides custom manufacturing and development of biodegradable materials for drug discovery & delivery, medical devices, biotechnology, electronics and analytical chemistry industries, as well as high purity optical monomers, UV absorbing materials and specialty polymer additives to the ocular lens industry. To learn more, please visit www.polysciences.com or call (215) 343-6484 about your next project.
Phosphorex is a provider of customized drug delivery solutions, specializing in sustained release, targeted delivery and solubility enhancement. Our service offerings include drug encapsulation in microspheres and nanoparticles, solid dispersion, micronization and nanosizing, with aseptic processing and cGMP manufacturing capabilities. We support all stages of drug development from proof of concept to clinical trials. For more information, please visit www.phosphorex.com.
NN, Inc Precision Engineered Products Group is a full service, vertically integrated FDA, ISO 9001, 13485 medical certified contract manufacturer of finished assemblies, sub-assemblies and precision components. We provide high quality, comprehensive, turnkey manufacturing services for the medical device and drug delivery markets. Learn more at www.pep-corp.com.
SMC Ltd. provides global contract manufacturing solutions of single-use devices for the pharmaceutical, medical and diagnostics industries. SMC provides full product services from initial concept through the final packaged device; including: program management, design and development, product manufacturing, clinical manufacturing, electronics integration, and global supply chain management. Visit www.smcltd.com
Team Consulting is a multi-award winning medical device product development consultancy based in Cambridge, UK. Our specialists in human factors, engineering and industrial design work closely with our clients to develop complex drug delivery and medtech devices from concept to launch. Learn more at www.team-consulting.com
URSATEC stands for innovative developments in preservative-free pharmaceutical, medical device and cosmetic products such as oral and nasal sprays. Safe protection against contamination by microorganisms, even after the opening of a package, is guaranteed by the dual microbiological protection of the patented dosing systems 3K® and COMFORT®. Learn more about us at www.ursatec.com/en.
Cam Med is commercializing its breakthrough design for a patient-friendly patch pump, the Evopump, which delivers one or multiple injectable medications more reliably and consistently than self-injections. Invisible under clothing, the ultra-thin and conformable Evopump overcomes the physical and psychological barriers that inhibit the majority of patients from wearing pumps. Learn more at www.myevopump.com
The Bettinger Group at Carnegie Mellon University is broadly interested in the applying principles of polymer synthesis, materials science, and microfabrication for use in a wide range of biomedical applications including advanced medical devices, regenerative medicine, bio-interfaces, and drug delivery. Members of the Bettinger Group work at the interface of several disciplines including polymeric biomaterials, electrochemistry, and applied physics to achieve these goals. One representative example of these efforts is our recent work in edible electronics. The goal of this project is to design and engineer sophisticated ingestible electronics that are composed of non-toxic materials and potentially useful in a wide range of diagnostic and therapeutic applications. Learn more at biomicrosystems.net.
Exicure, formerly AuraSense Therapeutics, is a clinical stage biotechnology company developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatory disorders to oncology. To learn more, visit www.exicuretx.com
NEUWAY Pharma, a German-based Biotech company, has developed a new revolutionary method for the delivery of drugs into the cells of the CNS. This method is based on NEUWAY`s proprietary engineered protein capsules (EPCs) which can be filled with various types of CNS relevant drugs. The EPCs are crossing the blood brain barrier after systemic administration and are delivering their cargo into the cells of the CNS. NEUWAY has shown proof-of-concept of its technology by delivering a luciferase coding gene to the CNS resulting in luciferase enzyme activity in the mouse brain.
Based on this technology, NEUWAY itself is focusing on the preclinical and clinical development of innovative therapeutics to treat rare diseases of the central nervous system (e.g. genetic diseases). Beside its own developments, NEUWAY Pharma intends to partner its CNS Drug Delivery Technology for application to proprietary compounds of pharmaceutical companies to enable their therapeutic use in the field of larger CNS indications like Alzheimer, Parkinson etc. Learn more at www.neuway-pharma.com
ProteoThera, Inc is an early stage biotechnology company that is advancing local drug targeting using its tissue matrix binding (MB) protein fusion platform technology to improve efficacy and safety of already validated systemic therapeutics and to address acute pain in diseases of the articular joints. Learn more at www.proteothera.com.
Founded in 2012, Rani Therapeutics has developed a novel approach for the oral delivery of peptides, proteins and therapeutic antibodies which to date can only be delivered through injections. Rani has a solid patent position with 30 patents issued and more than 80 patents filed. The approach and technology for Rani Therapeutics was developed at InCube Labs, a multi-disciplinary life sciences R&D lab focused on developing breakthrough medical innovations. InCube is led by Mir Imran, a prolific medical inventor, entrepreneur and investor, who has founded more than 20 life sciences companies and holds more than 400 patents issued and pending in the US. Many of Imran’s innovations have resulted in new standards of care, including the first FDA-approved Automatic Implantable Cardioverter Defibrillator. For more information, please visit: www.ranitherapeutics.com and www.incubelabs.com.
Recon Therapeutics has developed a new drug delivery technology that simplifies reconstitution of a lyophilized drug with solvent at the point of care. Instead of reinventing the syringe, our ‘LyoKit’ device can couple with standard off-the-shelf syringes through an external pressurized fluid chamber, resulting in a simple one-step reconstitution process. Learn more about us at www.recontherapeutics.com.